Background The proportion of total healthcare expenditures spent on drugs has continued to
grow in countries of all income categories. Policy‐makers are under pressure to control …

Background and objective: The uptake of new medicines is slower in the UK than in many
other countries. Previous research found that cost and price have little influence on general …

This paper presents and evaluates pharmaceutical policies in the EU aimed at the rational
use of medicines and at keeping pharmaceutical spending under control. Policy makers are …

OBJECTIVES: To explore and identify the key determinants influencing the uptake of
medicines use reviews (MURs), a new community pharmacy service in England. METHODS …

Abstract Background. The 2004 General Medical Services (GMS) contract introduced
financial incentives for the management of chronic illnesses in 10 clinical areas. The effect of …

Production of this report has been made possible through a financial contribution from
Health Canada. This report is published by the Health Council of Canada acting within its …

Randomized pragmatic trials of drugs, physician education and drug policies are needed to
improve pharmacosurveillance and cost‐effectiveness of prescribing. Since 1994, we have …

European policy makers have increasingly moved from primarily focusing on supply-side
regulation of pharmaceutical costs to offering incentives for providers' prescribing behavior …

医疗费用的增长及其控制是一个世界性的难题, 也是医疗保障研究的核心问题.
我国新型农村合作医疗中同样存在着不合理医疗费用增长的问题. 文章从委托代理理论视角分析 …

通过实证分析, 研究新型农村合作医疗制度中是否存在道德风险. 用“病例一对照” 方法,
选取安徽省第1 批新型农村合作医疗试点县中的6 个试点县. 2006 年仍未实行新型农村合作 …